Editorial

The Heidelberg classification of renal cell tumours

  1. Gyula Kovacs1,*,
  2. Mohammed Akhtar2,
  3. Bruce J. Beckwith3,
  4. Peter Bugert1,
  5. Colin S. Cooper4,
  6. Brett Delahunt5,
  7. John N. Eble6,
  8. Stewart Fleming7,
  9. Börje Ljungberg8,
  10. L. Jeffrey Medeiros9,
  11. Holger Moch10,
  12. Victor E. Reuter11,
  13. Eberhard Ritz1,
  14. Göran Roos8,
  15. Dietmar Schmidt12,
  16. John R. Srigley13,
  17. Stephan Störkel14,
  18. Eva Van Den Berg15,
  19. Bert Zbar16

Article first published online: 19 APR 1999

DOI: 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G

Issue

The Journal of Pathology

The Journal of Pathology

Volume 183, Issue 2, pages 131–133, October 1997

Additional Information

How to Cite

Kovacs, G., Akhtar, M., Beckwith, B. J., Bugert, P., Cooper, C. S., Delahunt, B., Eble, J. N., Fleming, S., Ljungberg, B., Medeiros, L. J., Moch, H., Reuter, V. E., Ritz, E., Roos, G., Schmidt, D., Srigley, J. R., Störkel, S., Van Den Berg, E. and Zbar, B. (1997), The Heidelberg classification of renal cell tumours. J. Pathol., 183: 131–133. doi: 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO;2-G

Author Information

  1. 1

    Ruprecht-Karls-University, Heidelberg, Germany

  2. 2

    King Faisal Specialist Hospital, Riyadh, Saudi Arabia

  3. 3

    Loma Linda University, Loma Linda, CA, U.S.A.

  4. 4

    Institute of Cancer Research, Sutton, U.K.

  5. 5

    Wellington School of Medicine, Newtown, New Zealand

  6. 6

    Roudebush VAMC, Indianapolis, IN, U.S.A.

  7. 7

    The University of Edinburgh Medical School, Edinburgh, U.K.

  8. 8

    Umea University, Umea, Sweden

  9. 9

    City of Hope National Medical Center, Duarte, CA, U.S.A.

  10. 10

    University of Basel, Basel, Switzerland

  11. 11

    Memorial Sloan-Kettering Cancer Center, New York, NY, U.S.A.

  12. 12

    Institute of Pathology, Mannheim, Germany

  13. 13

    University of Toronto, Toronto, Canada

  14. 14

    University of Witten/Herdecke, Wuppertal, Germany

  15. 15

    University of Groningen, Groningen, The Netherlands

  16. 16

    NCI-FCRDC, Frederick, MD, U.S.A.

*Department of Urology, Laboratory of Molecular Oncology, IM Neuenheimer Feld 365, 69120, Heidelberg, Germany.

Publication History

  1. Issue published online: 19 APR 1999
  2. Article first published online: 19 APR 1999
  3. Manuscript Accepted: 16 APR 1997
  4. Manuscript Received: 28 JAN 1997

Funded by

  • Deutsche Forschungsgemeinschaft
  • Else Kröner-Fresenius-Stiftung

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (32K)

Keywords:

  • kidney;
  • renal cell neoplasms;
  • classification;
  • genetics

Abstract

This paper presents the conclusions of a workshop entitled ‘Impact of Molecular Genetics on the Classification of Renal Cell Tumours’, which was held in Heidelberg in October 1996. The focus on ‘renal cell tumours’ excludes any discussion of Wilms' tumour and its variants, or of tumours metastatic to the kidneys. The proposed classification subdivides renal cell tumours into benign and malignant parenchymal neoplasms and, where possible, limits each subcategory to the most commonly documented genetic abnormalities. Benign tumours are subclassified into metanephric adenoma and adenofibroma, papillary renal cell adenoma, and renal oncocytoma. Malignant tumours are subclassified into common or conventional renal cell carcinoma; papillary renal cell carcinoma; chromophobe renal cell carcinoma; collecting duct carcinoma, with medullary carcinoma of the kidney; and renal cell carcinoma, unclassified. This classification is based on current genetic knowledge, correlates with recognizable histological findings, and is applicable to routine diagnostic practice. © 1997 John Wiley & Sons, Ltd.

Get PDF (32K)